CD177 Inhibitors

Sulfasalazine is known to inhibit the NF-kB pathway which is a critical pathway for the modulation of immune response and inflammation. CD177 is upregulated during inflammation and by immune cells, particularly neutrophils. By inhibiting NF-kB, sulfasalazine can reduce the activation of inflammatory pathways, thereby functionally inhibiting the action of CD177, which is associated with neutrophil activation and migration.

Dexamethasone is a corticosteroid that can suppress the immune response. It acts by inhibiting genes that encode for pro-inflammatory proteins and can inhibit the function of CD177 by reducing the inflammatory response in which CD177 is involved, particularly in neutrophil activation and function.

Aspirin acetylates and inhibits cyclooxygenase enzymes, leading to a decrease in the production of pro-inflammatory prostaglandins. Since CD177 is associated with neutrophil functions and immune responses, the reduction in inflammatory signaling by aspirin can lead to a functional inhibition of CD177 activity related to inflammation.

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes, decreasing the synthesis of prostaglandins involved in inflammation. By suppressing inflammatory pathways, ibuprofen can decrease the functional activity of CD177, which is implicated in the inflammatory response mediated by neutrophils.

Naproxen, another NSAID, inhibits the cyclooxygenase enzymes, reducing prostaglandin synthesis. This leads to a reduction in inflammation and can functionally inhibit CD177 by decreasing the inflammatory processes in which CD177 is involved, particularly neutrophil function.

Indomethacin works similarly to other NSAIDs by inhibiting cyclooxygenase, reducing inflammation. The suppression of the inflammatory response can consequently functionally inhibit CD177, which is upregulated in inflammation and by activated neutrophils.

Colchicine disrupts microtubule polymerization, affecting cell division and intracellular trafficking. By influencing neutrophil motility and activity, colchicine can functionally inhibit CD177, which plays a role in neutrophil-mediated immune responses.

Methotrexate is an antimetabolite that inhibits dihydrofolate reductase, leading to a reduction in DNA synthesis and cell proliferation. By affecting the proliferation of immune cells, methotrexate can indirectly inhibit CD177 functionality that is associated with immune cell (particularly neutrophil) activity.

Hydroxychloroquine is known to interfere with lysosomal activity and autophagy, which are processes that can affect immune cell function. By altering these cellular processes, hydroxychloroquine can functionally inhibit CD177 by affecting the cells in which CD177 is active.

Anakinra is an interleukin-1 receptor antagonist that inhibits the biological activity of interleukin-1. By interfering with the IL-1 pathway, anakinra can functionally inhibit the activity of CD177, which is involved in the immune response that IL-1 stimulates, particularly in neutrophils.